Welcome to CDC stacks | Report from the Advisory Committee on Immunization Practices (ACIP) : Decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4) - 7428 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Report from the Advisory Committee on Immunization Practices (ACIP) : Decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4)
Filetype[HTML]
View this content


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Keywords:
  • Pubmed ID:
    18451758
  • Description:
    At its February 2008 meeting, the Advisory Committee on Immunization Practices (ACIP) decided not to recommend routine vaccination of children aged 2--10 years against meningococcal disease unless the child is at increased risk for the disease. This report summarizes the deliberations of ACIP and the rationale for its decision and restates existing recommendations for meningococcal vaccination among children aged 2--10 years at increased risk for meningococcal disease. ACIP continues to recommend routine vaccination against meningococcal disease for all persons aged 11--18 years and those persons aged 2--55 years who are at increased risk for meningococcal disease (1--3).

  • Collection(s):
    Guidelines and Recommendations
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. MMWR. Morbidity and mortality weekly report, Vol. 57, no. 17, May 2, 2008
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    May 2, 2008
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 57, no. 17
    Description:
    Acute Renal Failure Associated with Cosmetic Soft-Tissue Filler Injections--North Carolina, 2007 -- Syncope After Vaccination--United States, January 2005-July 2007 -- Human Rabies--Minnesota, 2007 -- Report from the Advisory Committee on Immunizatio...
    File Type:
    Filetype[PDF - 335.43 KB]
  2. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    August 11, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(30):1018-9.
    Description:
    In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics), a quadrivalent meningococcal conjugate vaccine, to include persons aged 2 through 55 years. One other...
    Status:
    superseded
    File Type:
    Filetype[PDF - 72.15 KB]
  3. Recommended adult immunization schedule -- United States, 2012
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); American Academy of Family Physicians.; American College of Obstetricians and Gynecologists.; American College of Physicians.; American College of Nurse-Midwives;
    Published:
    February 3, 2012
    Source:
    MMWR. Morbidity and mortality weekly report QuickGuide. 2012; 61(04):1-7
    Series:
    MMWR. Morbidity and mortality weekly report QuickGuide
    Description:
    Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended adult immunization schedule to ensure that the schedule reflects current recommendations for licensed vaccines. In October 2011, ACIP approved the adult immuni...
    Status:
    superseded
    File Type:
    Filetype[PDF - 253.40 KB]
  4. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older -- United States, 2013
    Personal Author:
    Akinsanya-Beysolow, Iyabode; Bridges, Carolyn B.; Coyne-Beasley, Tamera; Jenkins, Renée; Meissner, H. Cody; Woods, LaDora;
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); American Academy of Family Physicians; American Academy of Pediatrics; United States, Advisory Committee on Immunization Practices., ACIP Adult Immunization Work Group.; United States, Advisory Committee on Immunization Practices., ACIP Childhood/Adolescent Immunization Work Group.;
    Published:
    February 1, 2013
    Source:
    MMWR. Morbidity and mortality weekly report ; v. 62, suppl.
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, suppl
    Description:
    Each year, recommendations for routine use of vaccines in children, adolescents, and adults in the United States are developed by the Advisory Committee on Immunization Practices (ACIP). This year, for the first time, recommended immunization schedul...
    Status:
    current
    File Type:
    Filetype[PDF - 14.95 MB]
  5. Manual for the surveillance of vaccine-preventable diseases. Chapter 8: Meningococcal disease
    Personal Author:
    MacNeil, Jessica R.; Cohn, Amanda C.;
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Published:
    Aug 2011
    Series:
    Manual for the surveillance of vaccine-preventable diseases ; chapter 8
    Description:
    Chapter 8 of: Manual for the surveillance of vaccine-preventable diseases. 5th Edition, 2011. : Meningococcal disease is a serious and potentially life-threatening infection caused by the bacterium Neisseria meningitidis. Common symptoms of meningoco...
    File Type:
    Filetype[PDF - 297.02 KB]